OTC: Latest News, Top Stories & Analysis

CAMBRIDGE, MA & MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) and Obsidian Therapeutics, Inc. recently entered into a definitive merger agreement in an all-stock transaction and secured commitments for …

Public Companies

Galera Therapeutics Sells Dismutase Mimetics Portfolio to Biossil in $108.5 Million Deal

October 30, 2025October 29, 2025 - by Timothy Alexander

MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) announced it has entered into an asset purchase agreement with Toronto-based Biossil Inc. for the sale of its dismutase mimetics portfolio, including …